« Back
Home /
ADL-08-0011

ADL-08-0011

Item no.	TMO-T20081-5mg
Manufacturer	TargetMol
CASRN	156130-41-5
Amount	5 mg
Quantity options	50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	Beattie DT, Cheruvu M, Mai N, O'Keefe M, Johnson-Rabidoux S, Peterson C, Kaufman E, Vickery R. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):205-20. Epub 2007 Mar 6. PubMed PMID: 17340127.
Smiles	C[C@@]1([C@@H](C)CN(C[C@H](CC2=CC=CC=C2)C(O)=O)CC1)C3=CC(O)=CC=C3
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	ADL 08-0011
Shipping condition	Cool pack
Available
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	367, 49
Target names or alias	ADL 08-0011
Description	ADL-08-0011 is an metabolite of alvimopan.
Pathways	Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T20081-5mg-datasheet.pdf

TMO-T20081-5mg-safety-datasheet.pdf